Pharmaxi LLC   Report issue

For profit Phase 1
Founded: Kiev Ukraine (2013)

Organization Overview

First Clinical Trial
2018
NCT04428684
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Pharmaxi LLC

Active Ingredients

Drugs in Phase 1 Trials (1)

treamid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hemorrhage (Phase 1)

Metrorrhagia (Phase 1)

Uterine Hemorrhage (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1